Pharma solutions

Unlock the future of inhaled medicine

Respiro empowers pharmaceutical companies to accelerate development, strengthen treatment outcomes, and innovate in value-based healthcare.

Transform patient and clinical experiences

Respiro helps patients build healthier habits, improve outcomes, and strengthen the bond with their clinicians. As a pharma partner, you’ll see how our proven platform supports adherence and delivers measurable, life-changing results.

Strengthen treatment adherence

Help patients stay consistent with their treatment and build habits that last.

Improve patient outcomes

Support better health through connected care and personalized insights.

Deepen patient–clinician loyalty

Enhance relationships with trusted, ongoing support that builds lasting connections.

Generate real-world evidence

Respiro transforms real-world inhaler data into actionable evidence—validating efficacy, accelerating development, securing market access, and differentiating your brand with clinically credible insights.

Optimize product development

Accelerate clinical trials with real-time insights linking drug usage to outcomes, enabling faster time-to-market and smarter decisions.

Support market access efforts

Validate drug performance and adherence with robust evidence, ensuring compliance, formulary inclusion, and stronger payer confidence.

Unlock outcomes-based opportunities

Demonstrate improved patient outcomes to reduce payer risk and achieve more favourable reimbursement terms.

Generate device-linked, inhalation-quality evidence competitors can’t get from claims or EHR data—clear, defensible differentiation for crowded classes.

Upgrading Inhaler Technology

Tap into the synergy of our partnership with Amcor to create Respiro-connected sensors that deliver valuable insights into medication use and inhalation quality. Our sensors are cost-effective and engineered for scalability, and can be integrated directly into your inhaler or offered as an optional add-on module.

Trusted data management and regulatory compliance

Respiro is developed under an ISO 13485:2016 quality system and delivered on secure cloud infrastructure. We support GDPR- and HIPAA-aligned deployments and provide documentation for EU MDR and US FDA regulatory pathways. Where applicable, components carry regional clearances—see our Data Management & Compliance page for details.

Unlock smarter inhaled therapies with Respiro. Let’s discuss how we can support your pipeline and market success.